applications published 10 january 2007

Published: 17-Jul-2007


Biodegradable ocular imp,ants with long-term release characteristics
Allergan 1740153*

Rapid acting drug delivery compsns
Biodel 1740154*

Polycyclic thiazoles as potassium ion channel modulators
Icagen 1740155*

Method for the production of an abuse-proof, solid form of administration
Gruenenthal 1740156*

Anti-excitotic sustained release intraocular implants and related methods
Allergan 1740157*

Pharmaceutical compsns for topical use in form of xerogels or films and methods for production
Switch Biotech; Ludwig-Maximilians-Universitaet 1740158*

Pharmanutrient compsn(s) and system(s) for individualised, responsive dosage regimens
Micro Nutrient 1740159*

Controlled delivery of therapeutic agents from medical articles
Boston Scientific Scimed 1740160*

Transdermal system secured against misuse
Gruenenthal 1740161*

Topical methadone compsns and methods for using the same
Caldwell Galer 1740162*

Multi-phase contraceptive preparation based on a natural oestrogen
Schering 1740163*

Statins for the treatment of ocular hypertension and glaucoma
Alcon 1740164*

Therapeutic agents, methods, and treatments
Medisyn Technologies 1740165*

Therapeutic antimicrobial compsns and methods
Procter & Gamble 1740166*

Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor
The Feinstein Institute for Medical Research 1740167*

Antiprostaglandins for the treatment of ocular pathologies
Advanced Ocular Systems 1740168*

Immunomodulating agent, anti-cancer agent and health food containing monoacetyldiacylglycerol derivatives
Kim, Sang Hee 1740169*

Combination therapy with AZD2171 and platinum anti-tumour agent
AstraZeneca 1740170*

Indol-1-yl-acetic acid derivatives
Actelion Pharmaceuticals 1740171*

Acetylcholinesterase inhibitors and N-methyl-D-aspartate antagonists useful in the treatment of cognitive disorders
Axonyx 1740172*

Azabicyclo-octane inhibitors of IAP
Genentech 1740173*

Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of enuresis
Laboratorios del Dr Esteve 1740174*

Use of a CGRP-antagonist combined with a serotonin-reuptake inhibitor in order to treat migraines
Boehringer Ingelheim International 1740175*

Pharmaceutical compsns comprising anti-inflammatory quinazolinecarboxamide derivatives
Rimonyx Pharmaceuticals 1740176*

Muscarinic acetylcholine receptor antagonists
Glaxo Group 1740177*

Methods and compsns for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
Celgene 1740178*

Method of treating neuropathic pain using a CRTH2 receptor antagonist
Pfizer Ltd; Pfizer Inc 1740179*

Use of flibanserin in the treatment of premenstrual and other female sexual disorders
Boehringer Ingelheim Pharmaceuticals 1740180*

New pharmaceutical compsns for the treatment of sexual disorders II
Boehringer Ingelheim International 1740181*

Use of 5,10-methylene tetrahydrofolate for the treatment of cancer
Robbins, Joan; Cantwell, Mark; Adventrx Pharmaceuticals 1740182*

Novel use for PDE5 inhibitors
Altana Pharma 1740183*

Combinations of signal transduction inhibitors
Pfizer 1740184*

Benzodiazepines for treating or preventing RSV infection
Arrow Therapeutics 1740185*

Biodegradable intraocular implants containing prostamides
Allergan 1740186*

Macular edema patient selection method and treatment with eye implant comprising a steroid
Bausch & Lomb 1740187*

Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
Altana Pharma 1740188*

Lung surfactant supplements
Centre National de la Recherche Scientifique; Universite Louis Pasteur Industrie 1740189*

Use of a mixture for the production of an agent for treating defective or degenerated cartilage in the production of natural cartilage in vitro
Synthes 1740190*

Use of equol for treating skin diseases
Brigham Young University; Children's Hospital Medical Centre; The Colorado State University Research Foundation 1740191*

Method for stimulating the immune, inflammatory or neuroprotective response
Karaolis, David 1740192*

Macromolecule-containing sustained release intraocular implants and related methods
Allergan 1740193*

Method of suppressing post-harvest biological infestation and disease in fruit
The International Group 1740194*

Extract of Nelumbinis semen for the treatment of depression, medicinal composite and health foods including the extract of Nelumbinis semen
Purimed 1740195*

Compsns and method for alleviating inflammation and oxidative stress in a mammal
Lifeline Nutraceuticals 1740196*

Therapeutic enzyme formulations and uses thereof
Celiac Sprue Research Foundation; The Board of Trustees of the Leland Stanford Junior University 1740197*

Anti-ageing effects of substance P
ImmuneRegen BioSciences 1740198*

IL6R/IL6 chimera for therapy of chemotherapy-induced peripheral neuropathy
Yeda Research and Development 1740199*

IL-6 for therapy or prevention of chemotherapy-induced neuropathy
Applied Research Systems 1740200*

Pharmaceutical compsn comprising interferon-tau
Pepgen 1740201*

Use of luteinising hormone (LH and chorionic gonadotropin (HCG) for proliferation of neural stem cells and neurogenesis
Stem Cell Therapeutics 1740202*

Polypeptide inducing the secretion of angiopoietin
Eyegene 1740203*

Medicinal use of alpha-mannosidose
Zymenex 1740204*

Vaccination against malignant melanoma using BCG and/or vaccinia
Georg-August-Universitaet Stiftung oeffentlichen Rechts 1740205*

Phep, an amino acid permease of staphylococcus aureus
The University of Sheffield 1740206*

Antigen delivery vectors and constructs
ImmuneTargeting Systems 1740207*

Monoclonal antibodies specific for human OX40L (CD134L)
Amgen 1740208*

Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients
Biophoresis Technologies 1740209*

IRTA-5 antibodies and their uses
Medarex 1740210*

Combinations comprising alpha-2-delta ligands and EP4 receptor antagonists
Pfizer Products 1740211*

Pharmaceutical compsns comprising beta-carboline derivatives and use thereof for the treatment of cancer
Centre National de la Recherche Scientifique 1740212*

Liquid growth hormone formulation
Ares Trading 1740213*

Method of stabilising disordered cefovecin sodium salt
Pfizer Products; University of Connecticut 1740214*

Thiopeptide conjugates for drug delivery
The University of Manchester 1740215*

Antibody calicheamicin conjugates
Wyeth 1740216*

Meningococcal conjugate vaccination
Chiron 1740217*

Materials for treating vascular leakage in the eye
Genvec 1740218*

Non-natural ribonuclease conjugates as cytotoxic agents
Quintessence Biosciences 1740220*

Methods and compsns for the treatment of polycystic diseases
Genzyme Corp 1740221*

You may also like